Promising Signals Emerge from Two Phase II Cancer Studies

Two biopharma companies developing therapeutics in the oncology space reported strong signals in Phase II.

Tetra Bio-Pharma made the cut in two ongoing clinical trials for its novel cannabinoid-derived drug aimed at alleviating the pain experienced by cancer patients.